News & press

An overview of press releases and news.

EconoComfortOxypoint launches the first high-precision dosing system specially designed for O2 therapy in hospitals.

Oxypoint successfully raises €3.8 million in series A funding

Wednesday March 28th, 2018

Antwerp, March 28th, 2018 – Oxypoint nv, the award-winning University of Antwerp spin-off, bringing innovation to the medical device market for oxygen therapy in hospitals, announced the closing of a €3.8 million Series A financing round led by the Flemish investment company PMV, together with a family office. The investment round was guided by Wouter Van Roost, who was appointed CEO of the company. The company will use the proceeds to bring its unique proprietary CE-labelled Econo-Comfort Oxygen Flowmeter™ to the European market and to further expand its product range of novel oxygen-therapy administering medical devices.

Oxypoint artwork ENG

Intensified commercial efforts
We are delighted with this significant boost for our company”, said Philip Hendrickx, founder of Oxypoint. “There is nothing more encouraging than to see efforts rewarded by sizeable financial investments. Having sold 2000 Econo-Comfort Oxygen Flowmeters™ in our home market, we can now confidently conquer Europe!”

Oxypoint will expand its commercial footprint through a network of specialized distributors across Europe. The initial focus markets are the Benelux, the DACH countries, Italy, France, Spain and the UK. In a later stage, Oxypoint aims to enter markets in the Far East and North America.

A family of products
When we started 7 years ago, I could not have imagined the overwhelming positive market response we would receive”, adds Dirk Borgonjon, co-founder. “We saw an opportunity to bring innovative thinking to the traditional oxygen flowmeters and here we are – seven years later – introducing our innovative oxygen administering medical device to the world hospital market.

The CE-marked Econo-Comfort Oxygen Flowmeter™ uses Oxypoint’s patented technology, combining a traditional flowmeter with a pneumatic on-demand oxygen delivery valve. The combination of these two administering principles allows hospital nursing staff to switch from a conventional, continuous oxygen flow delivery to an innovative patient-friendly on-demand setting. The on-demand setting delivers an adjustable dose of oxygen at the start of the inhalation phase. The benefit to the patient is a vastly improved comfort due to a reduced nasal dehydration and a higher therapy adherence. Hospitals benefit from lowered spillage and improved oxygen therapy.

“I am delighted to see that Oxypoint is now able to expand its market penetration in Europe and beyond, thus enhancing the comfort of patients while at the same time reducing cost and thereby optimising the scarce hospital resources. PMV strongly believes in Oxypoint’s commercially validated and CE-marked technology and is happy to assist the company to fully capture its growth potential,” says David Devigne, senior investment manager at PMV.

For more information contact Philip Hendrickx at Oxypoint (philip.hendrickx@oxypoint.eu)

About Oxypoint
Oxypoint was founded in 2011 by Dirk Borgonjon and Philip Hendrickx and aims to significantly improve the efficiency of Oxygen therapy in hospitals by making Oxygen-administering more comfortable for the patients while reducing the spillage associated with traditional Oxygen flowmeters. The company has sold its flowmeters to 20 hospitals in Flanders and the Brussels region and counts several reference hospitals among its user base. It currently employs 5 people and plans to double its headcount within the next 15 months.

About PMV
PMV is a do and dare company that shapes the economic future of Flanders. PMV finances promising companies from the very start to growth and internationalization. PMV offers tailor-made financial solutions for every entrepreneur with a solid business plan and a strong management team, by providing venture capital, loans and guarantees. An experienced and highly motivated team of 125 professionals endeavors every day to achieve the goal of creating prosperity and well-being in Flanders. By the end of 2017, PMV had a portfolio of about EUR 1.2 billion in assets under management. More info: www.pmv.eu


Philip convinces on VLAIO info session at Research Park Waterfront

Thursday February 8th, 2018

Innovation requires taking risks. The Flemish Government therefore supports companies during research and development projects. The Innovation and Entrepreneurship Agency asked Philip Hendrickx of Oxypoint to give a company testimonial to entrepreneurs with intention to innovate at the University Science Park Waterfront in Niel.

Gerelateerde afbeelding


Oxygen for Rotary Heideland

On February 8th, 2018 Dirk provided the members of Rotary club Antwerp-Heideland with some extra oxygen. The meeting took place in the old brewery in Hoevenen. The members were pleasantly surprised by the nice combination of the entrepreneurial story behind Oxypoint and a practical live demonstration of the Oxypoint comfort oxygen dosing system for hospitals. Afterwards there were a lot of enthusiastic questions from the members which Dirk was only too happy to answer. It was nice to experience the cordial and positive atmosphere of the meeting.

DIIIRK


‘Healthcare & Life Science’ debate, moderated by Hanne Decoutere, with Philip as keynote speaker

Friday February 2nd, 2018

Philip was invited to present the entrepreneurial story of Oxypoint on the road show “Upcycle your business transformation” in the beautiful ING office Metropool. Philip took a knee for the charming Hanne Decoutere, presenter VRT news, to give her a demonstration of Oxypoint’s Econo-ComfortTM Oxygen Flowmeter with comfort mode. The main focus of the event was health & life science, so Oxypoint’s innovative technology fitted perfectly. Philip thanked the government for its support through awarded innovation and growth subsidies, and for the powerful network of VLAIO, Innovation Center, PMV, FIT, which puts a lever on performance. A nice wish for young entrepreneurs would be when customers such as hospitals would receive a direct subsidy for the use of groundbreaking technology. Clients who are motivated to buy innovative solutions would certainly be a strong incentive for the entrepreneurial landscape.


Oxypoint is happy with Flemish government’s positive decision to assign growth subsidies

Thursday February 1st, 2018

2017 will be a tipping point for Oxypoint. In 2017, the company will be turned around from a single-product start-up with a small team selling into the local market (Flanders), to a scale-up with a larger team offering a range of products in a hybrid product/service model. This has far-reaching impact on all aspects of business operations and business processes. Fortunately, the Flemish government supports healthy innovative projects with growth potential. Government support not only comes financially in the shape of grants, but also with substantial associated services and specialists to ensure that the transition happens smoothly.

Vlaio16


University Antwerp Faculty of product development uses Oxypoint as case-story in master’s thesis brochure

Tuesday January 2nd, 2018

The Oxypoint team receives a nice spot in the new brochure of the faculty of product development at the University of Antwerp! For the third time in a row already, Oxypoint fulfilled the role of industrial promoter during a master’s thesis project of the faculty. By working closely together, the topics provided by Oxypoint always turned into promising concepts. We hope this beautiful collaboration may continue in the future!

Mockups Design


Oxypoint receives crosscare funding

Saturday December 23rd, 2017

This project brings a solution to the current problems facing oxygen therapy in hospitals. The vision of Oxypoint is an optimized oxygen therapy, with increased comfort and mobility for the patient. In close cooperation with the Belgian and Dutch testing labs Licalab and Slimmer Leven, the concept is tested with the various stakeholders in the hospital through iterative co-creation sessions and user tests. By integrating the patented Oxypoint technology and by responding to current trends and opportunities such as Internet of Things (IoT) as well as enhanced personalization, Oxypoint introduces oxygen therapy to the 21st century.

CrossCare_Logo_FINA600

Schermafbeelding 2018-03-28 om 16.37.13


Oxypoint is looking for qualified international distributors

Tuesday November 14th, 2017

Oxypoint’s innovative and CE-labelled Econo-ComfortTM Flowmeter has been very successful in the Belgian market with over 2.000 units sold, implemented in 20 hospitals. In view of its expanding commercial footprint, Oxypoint is actively looking for distributors in Germany, Switzerland, Austria, France, Italy, Spain and the UK. Distributors will be selected on the basis of their expertise in the field of Oxygen-therapy, their knowledge of the local market and the specific sales dynamics in the hospitals they serve.


Oxypoint receives KMO innovation funding

Oxypoint has received innovation support to develop, in close collaboration with other innovative players, the next generation of intelligent hospital O2 solutions into prototypes.

Vlaio16


Oxypoint participates in the EIT Health Launchlab Bootcamp

Friday November 3rd, 2017

After a very challenging and extensive process involving no less than 80 MedTech start-ups across Europe, Oxypoint was selected for participation in this year’s EIT Health Bootcamp Launchlab at YES!Delft (#2 World Top Business Incubator according to UBI global). Oxypoint’s goal for participating in this program was to further explore the potential for its ‘smart oxygen therapy’ concept. Through its participation in the Bootcamp, the Oxypoint team explored the market potential in Europe and started to design the most appropriate business models. This discovery journey took Oxypoint on a trip from The Netherlands, Belgium and Germany to Sweden. It allowed us to get in touch with several reputable parties and meet up with leading industry partners, such as BioM, Erasmus MC, Imec, RISE, TU Delft, Uppsala University and organisations like Medical Delta, LUMC, Roche and NLC.

This bootcamp was a success for Oxypoint. Oxypoint was able to further define the product/market fit by interviewing a wide selection of stakeholders and companies. Meetings in the different countries also provided Oxypoint with very valuable information concerning successful product launches in the specific countries.

EIT


Oxypoint’s O2NOME project is part of the ‘We are the next generation’ design exhibition

Sunday October 22nd, 2017

From October 18th till October 22nd 2017, Oxypoint’s O2NOME project was on display during the ‘Week of Design’ at the Budafabriek in Kortrijk. This annual event exhibits the most promising  projects of creative Flemish design students. Our innovative prototype stood proud amongst the interesting design of the ‘We Are The Next Generation’ exhibition, thé highlight of this event.

WVHO2

 


Cedric earns silver at OVAM EcoDesign student Awards 2017

Friday October 20th, 2017

On October 20th of 2017, the OVAM Ecodesign Awards 2017 for students were awarded at the Budafabriek in Kortrijk, during the ‘Week of Design’. This is an annual event in which OVAM recognizes projects that focus on sustainability. This year, a jury of experts and professionals awarded O2NOME the second prize in the category ‘final thesis’. O2NOME was developed by Cedric Van Steenkiste in collaboration with Oxypoint. Cedric received a cash prize and further coaching for O2NOME by Flanders DC, thé point of contact for the creative sector.

foto ecodesign award


Oxypoint expands further with Cedric van Steenkiste

Sunday October 1st, 2017

Oxypoint expands further with the arrival of product developer Cedric van Steenkiste.

He has  a background in product development. He focuses primarily on the technical / human aspects within the field. This ranges from identifying specific market needs (with hospital visits in the Flemish region for validation) to generating innovative technical solutions. In addition, he also deals with all marketing aspects of Oxypoint.

Cedric


Oxypoint embraces the principles of the Innovative Organisation!

Tuesday September 5th, 2017

Because of its ambitious goal to capture the European market in the next few years -while maintaining a nimble organisation- Oxypoint decided to use an innovative working method to build its Human Capital foundation. This working method is based on a combination of deep-personal-intrinsic motivators with an optimisation of the interaction between the team members. For the personal profiling and setting up the optimal interaction, Oxypoint is using the tools and experience of Wouter Van Roost through his company FACTOR+. Under the guidance of FACTOR+, management will be able not only to assemble a high-performance team based on intrinsic motivators and acquired competences, but also maximize the efficiency of the team by making sure that from the very beginning a high-performance type of interaction exists between all the team-members. This way -and in line with other high-performance organisations- Oxypoint strives to substantially outperform its peers in the industry while keeping the operational costs low.

Factor Plus logo


Jessa expands its implementation to the geriatrics wards

Thursday August 3rd, 2017

Jessa is expanding its use of the Econo-Comfort O2 flowmeter from the pneumology departement to the geriatrics departments on campus salvatore and campus virga jesse.

 Print


About us

Oxypoint is the partner par excellence for the optimization of oxygen therapy in hospitals.

Contact

Oxypoint
info@oxypoint.eu

Philip Hendrickx
+32 (0)496 03 27 76

Dirk Borgonjon
+32 (0)486 44 51 62

(c) 2016 Oxypoint I Jobs I Terms and conditions I All rights reserved I Patented technology

Menu